Paraneoplastic pemphigus and reported, identified underlying diseases
DOI:
https://doi.org/10.12775/JEHS.2023.58.005Keywords
paraneoplastic pemphigus, dermatology, oncology, skinAbstract
Introduction: Pemphigus is a rare group of autoimmune diseases that promote development of various skin eruptions, the most commonly it presents with blisters. The several types of pemphigus are: pemphigus vulgaris, pemphigus foliaceus, intraepidermal neutrophillic IgA dermatosis and especially rare type- paraneoplastic pemphigus, which is main topic of this publication. Paraneoplastic pemphigus is a disease which affects patients with developing carcinogenesis process. Usually it is a malignant process, but there are also some cases which describe paraneoplastic pemphigus associated with benign tumors. Because of its occurence our current level of knowledge about different aspects of paraneoplastic pemphigus is not final and as comprehensive as researchers and patients wish.
Aim of study: The main purpose of this publication is presentation a review of literature about paraneoplastic pemphigus- its epidemiology, physiopathology, pathomorfology, clinical features, and description of different types of benign or malignant processes which concomitence with paraneoplastic pemphigus.
State of knowledge: Paraneoplastic pemphigus is a rare autoimmune disease, which aspects are not widely described, but there are some reports about epidemiology, pathophysiology, histopathology, treatment and associated confirmed malignancies. The challenge for future is to formulate clear, formal, treatment protocols for paraneoplastic pemphigus.
Conclusion: Paraneoplastic pemphigus is a very fascinating disease for researchers because there are still very limited reports and statistics about this very rare disorder. Nonetheless year by year our level of knowledge about pathogenesis, clinical features, associated malignant and benign processes is growing and it can affect more personalized, effective treatment methods and protocoles.
References
Jelti L, Cordel N, Gillibert A, Lacour JP, Uthurriague C, Doutre MS, Delaporte E, Duvert-Lehembre S, Quereux G, Dupuy A, Adamski H, Bedane C, Misery L, Abasq Thomas C, Fleuret C, Bernard P, Chaby G, D'incan M, Verneuil L, Litrowski N, Joly P; French Study Group on Autoimmune Blistering Diseases. Incidence and Mortality of Pemphigus in France. J Invest Dermatol. 2019 Feb;139(2):469-473. doi: 10.1016/j.jid.2018.07.042. Epub 2018 Sep 17. PMID: 30236611.
Ohzono A, Sogame R, Li X, Teye K, Tsuchisaka A, Numata S, Koga H, Kawakami T, Tsuruta D, Ishii N, Hashimoto T. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015 Dec;173(6):1447-52. doi: 10.1111/bjd.14162. Epub 2015 Nov 14. PMID: 26358412.
Mimouni D, Anhalt GJ, Lazarova Z, Aho S, Kazerounian S, Kouba DJ, Mascaro JM Jr, Nousari HC. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol. 2002 Oct;147(4):725-32. doi: 10.1046/j.1365-2133.2002.04992.x. PMID: 12366419.
Kappius RH, Ufkes NA, Thiers BH. Paraneoplastic Pemphigus. 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31536300.
Wieczorek M, Czernik A. Paraneoplastic pemphigus: a short review. Clin Cosmet Investig Dermatol. 2016 Sep 23;9:291-295. doi: 10.2147/CCID.S100802. PMID: 27729809; PMCID: PMC5042195.
Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin. 2011 Jul;29(3):419-25, viii. doi: 10.1016/j.det.2011.03.018. PMID: 21605807.
Chen C, Xu Y, Yu J, Qian S, Xie Y. A first case of successful using of ibrutinib in treating paraneoplastic pemphigus related bronchiolitis obliterans concurrent with CLL. Front Med (Lausanne). 2023 Mar 15;10:1132535. doi: 10.3389/fmed.2023.1132535. PMID: 37007770; PMCID: PMC10056216.
Kuriyama K, Kitamura Y, Tsuji T, Nishikawa R, Nagata H, Ohshiro M, Sugitani M, Hirakawa Y, Matsumoto Y, Iwai T, Uchiyama H. Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine. Curr Probl Cancer. 2022 Apr;46(2):100813. doi: 10.1016/j.currproblcancer.2021.100813. Epub 2021 Nov 19. PMID: 34844771.
Svoboda SA, Huang S, Liu X, Hsu S, Motaparthi K. Paraneoplastic pemphigus: Revised diagnostic criteria based on literature analysis. J Cutan Pathol. 2021 Sep;48(9):1133-1138. doi: 10.1111/cup.14004. Epub 2021 Apr 17. PMID: 33719070.
Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt GJ, Calderon S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol. 2004 Jul;40(6):553-62. doi: 10.1016/j.oraloncology.2003.09.020. PMID: 15063382.
Sapkota S, Shaikh H. Non-Hodgkin Lymphoma. 2023 Feb 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32644754.
van der Waal RI, Pas HH, Anhalt GJ, Schulten EA, Jonkman MF, Nieboer C. Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue. Oral Oncol. 1998 Nov;34(6):567-70. doi: 10.1016/s1368-8375(98)00020-7. PMID: 9930372.
Baykal C, Kılıç S, Küçükoğlu R. Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab. J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e50-e52. doi: 10.1111/jdv.14500. Epub 2017 Aug 23. PMID: 28758262.
Zengin N, Kars A, Kansu E, Özdemir O, Barişta İ, Güllü İ, Güler N, Özişik Y, Dündar S, Firat D. Comparison of Rai and Binet Classifications in Chronic Lymphocytic Leukemia. Hematology. 1997;2(2):125-9. doi: 10.1080/10245332.1997.11746327. PMID: 27406802.
Cao L, Wang F, Du XY, Zhu HY, Wang L, Xu W, Li JY, Fan L. Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies. Sci Rep. 2020 Oct 1;10(1):16357. doi: 10.1038/s41598-020-73131-y. PMID: 33004832; PMCID: PMC7529904.
Ehsan N, Zahra F. Castleman Disease. 2023 Apr 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 35015419.
Irrera M, Bozzola E, Cardoni A, DeVito R, Diociaiuti A, El Hachem M, Girardi K, Marchesi A, Villani A. Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature. Ital J Pediatr. 2023 Mar 20;49(1):33. doi: 10.1186/s13052-023-01442-7. PMID: 36941723; PMCID: PMC10029234.
Barry KK, Plumptre I, Bazewicz CG, Green BP, Treat JR, Hughes M, Morel KD, Wiss K, Liang MG. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series. Pediatr Dermatol. 2023 Jan;40(1):90-95. doi: 10.1111/pde.15138. Epub 2022 Sep 20. PMID: 36128651.
Moata H, Hali F, Zafad S, Jouhadi H, Chiheb S. Recalcitrant Paraneoplastic Pemphigus Associated With Prostate Adenocarcinoma: Spectacular Evolution Under Androgen Deprivation. Cureus. 2023 Aug 16;15(8):e43585. doi: 10.7759/cureus.43585. PMID: 37719500; PMCID: PMC10503779.
Martínez De Pablo MI, Iranzo P, Mascaró JM, Llambrich A, Baradad M, Herrero C. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol. 2005;85(3):233-5. doi: 10.1080/00015550510025542. PMID: 16040408.
Lim JM, Lee SE, Seo J, Kim DY, Hashimoto T, Kim SC. Paraneoplastic Pemphigus Associated with a Malignant Thymoma: A Case of Persistent and Refractory Oral Ulcerations Following Thymectomy. Ann Dermatol. 2017 Apr;29(2):219-222. doi: 10.5021/ad.2017.29.2.219. Epub 2017 Mar 24. PMID: 28392652; PMCID: PMC5383750.
Shirai T, Kiniwa Y, Ishii N, Hashimoto T, Senoo Y, Urushihata K, Ashida A, Okuyama R. Paraneoplastic pemphigus associated with Waldenström's macroglobulinemia. J Dermatol. 2020 May;47(5):e200-e201. doi: 10.1111/1346-8138.15289. Epub 2020 Feb 27. PMID: 32103535.
Perera GK, Devereux S, Mufti G, Salisbury J, Creamer D. PNP with Waldenström's macroglobulinaemia. Clin Exp Dermatol. 2005 Jan;30(1):27-9. doi: 10.1111/j.1365-2230.2004.01599.x. PMID: 15663497.
Gaurav V, Pandhi D, Sharma S, Rastogi S. Renal cell carcinoma-induced paraneoplastic pemphigus. Indian Dermatol Online J. 2022 May 5;13(3):407-410. doi: 10.4103/idoj.idoj_390_21. PMID: 36226024; PMCID: PMC9549559.
Zaheri F, Pas HH, Bremer J, Meijer JM, Bolling MC, Horvath B, Diercks GFH. Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical cases. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):147-153. doi: 10.1111/jdv.18557. Epub 2022 Sep 6. PMID: 35993495; PMCID: PMC10087213.
Lynch HM, Beslow LA, Treat JR, Corcoran A, Lin JH, Gunawardena N, Maris JM, Behrens EM. Paraneoplastic myasthenia gravis and pemphigus associated with follicular dendritic cell sarcoma leading to cardiorespiratory collapse in a 7-year-old. Pediatr Blood Cancer. 2022 Nov;69(11):e29723. doi: 10.1002/pbc.29723. Epub 2022 Apr 29. PMID: 35484988.
Liu L, Deng J, Cibull T, Pesce CE. Invasive breast cancer found in a patient with new-onset pemphigus foliaceus. JAAD Case Rep. 2021 Oct 23;18:67-70. doi: 10.1016/j.jdcr.2021.10.014. PMID: 34841027; PMCID: PMC8606302.
Yee MD, Seline A, Young K, Wanat KA. Paraneoplastic pemphigus secondary to neuroendocrine carcinoma. JAAD Case Rep. 2021 Jul 15;15:22-25. doi: 10.1016/j.jdcr.2021.07.006. PMID: 34386565; PMCID: PMC8342845.
Liska J, Liskova V, Trcka O, Ondic O, Hauer L, Baxa J, Kacerovska D. Oral presentation of paraneoplastic pemphigus as the first sign of tonsillar HPV associated squamous cell carcinoma. A case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Dec;166(4):447-450. doi: 10.5507/bp.2021.039. Epub 2021 Jun 28. PMID: 34188253.
Poonia K, Chabra K, Dalal U, Bhalla M. Toxic epidermal necrolysis-like presentation of paraneoplastic pemphigus due to underlying thymoma: A clinical conundrum. J Postgrad Med. 2021 Apr-Jun;67(2):119-121. doi: 10.4103/jpgm.JPGM_752_20. PMID: 33942776; PMCID: PMC8253326.
Khurana R, Sharma S, Kumar S, Deshpande AA, Wadhwa D, Agasty S. Paraneoplastic pemphigus associated with a pericardial ectopic thymoma. J Card Surg. 2020 Nov;35(11):3141-3144. doi: 10.1111/jocs.14955. Epub 2020 Aug 25. PMID: 32840923.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paweł Iwańczuk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 229
Number of citations: 0